Nuvalent (NUVL) Prepaid Assets (2020 - 2026)
Nuvalent (NUVL) reported Prepaid Assets of $20.5 million for Q1 2026, up 53.52% on a YoY basis from $13.3 million in Q1 2025, and little changed quarter-over-quarter from $20.5 million in Q4 2025.
Nuvalent (NUVL) Prepaid Assets (2020 - 2026) Analysis & Trends
Nuvalent has reported Prepaid Assets for 7 years, with the latest figure at $20.5 million in Q1 2026.
- For the quarter ending Q1 2026, Prepaid Assets rose 53.52% year-over-year to $20.5 million; the trailing twelve-month figure through Mar 2026 stood at $20.5 million (up 53.52% YoY), and the FY2025 full-year result was $20.5 million, up 44.73% from the prior year.
- Prepaid Assets for Q1 2026 stood at $20.5 million, roughly flat from $20.5 million in the prior quarter.
- The five-year high for Prepaid Assets was $20.5 million in Q4 2025, with the low at $1.7 million in Q1 2022.
- Historically, Prepaid Assets has averaged $9.6 million across 5 years, with a median of $7.7 million in 2024.
- Annual changes were most pronounced in 2022 — Prepaid Assets soared 413.26% — and 2023, when it increased 12.95%.
- Nuvalent's Prepaid Assets stood at $5.8 million in 2022, then increased by 12.95% to $6.6 million in 2023, then soared by 114.89% to $14.1 million in 2024, then surged by 44.73% to $20.5 million in 2025, then dropped by 0.06% to $20.5 million in 2026.
- The last three Prepaid Assets figures came in at $20.5 million (Q1 2026), $20.5 million (Q4 2025), and $13.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Nuvalent | 9.70 Bn | 9.70 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 20.46 Mn |
| Dec 31, 2025 | 20.47 Mn |
| Sep 30, 2025 | 13.84 Mn |
| Jun 30, 2025 | 14.01 Mn |
| Mar 31, 2025 | 13.33 Mn |
| Dec 31, 2024 | 14.15 Mn |
| Sep 30, 2024 | 11.37 Mn |
| Jun 30, 2024 | 8.26 Mn |
| Mar 31, 2024 | 7.66 Mn |
| Dec 31, 2023 | 6.58 Mn |
| Sep 30, 2023 | 6.52 Mn |
| Jun 30, 2023 | 5.75 Mn |
| Mar 31, 2023 | 5.83 Mn |
| Dec 31, 2022 | 5.83 Mn |
| Sep 30, 2022 | 5.18 Mn |
| Jun 30, 2022 | 1.86 Mn |
| Mar 31, 2022 | 1.74 Mn |
| Dec 31, 2021 | 2.52 Mn |
| Sep 30, 2021 | 2.71 Mn |
| Jun 30, 2021 | 362,000.00 |